Hasan, K. M., Elmeshhadany, A. Y. and Shabila, N. P. (2022) “Evaluation of Ruxolitinib versus Best Available Therapy in Treating Primary Myelofibrosis”, Sultan Qaboos University Medical Journal, 22(3), pp. 393–399. doi: 10.18295/squmj.8.2021.110.